FDA Drops List Of Off-Patent Drugs Without Approved Generic
The U.S. Food and Drug Administration published its updated list of off-patent, off-exclusivity drugs, or OPOEs, without an approved generic on Tuesday, encouraging drugmakers to bring new generics into the market....To view the full article, register now.
Already a subscriber? Click here to view full article